Zfp521 SUMOylation facilities erythroid hematopoietic reconstitution under stress

References

• Dzierzak E, Bigas A. Blood development: hematopoietic stem cell dependence and independence. Cell Stem Cell. 2018;22(5):639–651.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gao S, Xia J, et al. Hematopoietic hierarchy – an updated roadmap. Trends Cell Biol. 2018;28(12):976–986.
   PubMed Web of Science ®Google Scholar
• Dharampuriya PR, Scapin G, Wong C, et al. Tracking the origin, development, and differentiation of hematopoietic stem cells. Curr Opin Cell Biol. 2017;49:108–115.
   PubMed Web of Science ®Google Scholar
• Zon LI. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature. 2008;453(7193):306–313.
   PubMed Web of Science ®Google Scholar
• Takizawa H, Manz MG. Impact of inflammation on early hematopoiesis and the microenvironment. Int J Hematol. 2017;106(1):27–33.
   PubMed Web of Science ®Google Scholar
• Shimoto M, Sugiyama T, Nagasawa T. Numerous niches for hematopoietic stem cells remain empty during homeostasis. Blood. 2017;129(15):2124–2131.
   PubMed Web of Science ®Google Scholar
• Pardo-Saganta A, Tata PR, Law BM, et al. Parent stem cells can serve as niches for their daughter cells. Nature. 2015;523(7562):597–601.
   PubMed Web of Science ®Google Scholar
• Wei Q, Frenette PS. Niches for hematopoietic stem cells and their progeny. Immunity. 2018;48(4):632–648.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang W, Ran Q, et al. The differentiation balance of bone marrow mesenchymal stem cells is crucial to hematopoiesis. Stem Cells Int. 2018;2018:1540148.
   PubMed Web of Science ®Google Scholar
• Gordon MY, Blackett NM. Reconstruction of the hematopoietic system after stem cell transplantation. Cell Transplant. 1998;7(4):339–344.
   PubMed Web of Science ®Google Scholar
• Storek J, Geddes M, Khan F, et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol. 2008;30(4):425–437.
   PubMed Web of Science ®Google Scholar
• Ogonek J, Kralj Juric M, Ghimire S, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2016;7:507.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang B, Wang S, et al. Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation. Sci Rep. 2015;5:12993.
   PubMed Web of Science ®Google Scholar
• Baron F, Nagler A. Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy. Expert Opin Biol Ther. 2017;17(2):163–174.
   PubMed Web of Science ®Google Scholar
• van der Maas NG, Berghuis D, van der Burg M, et al. B cell reconstitution and influencing factors after hematopoietic stem cell transplantation in children. Front Immunol. 2019;10:782.
   PubMed Web of Science ®Google Scholar
• de Koning C, Nierkens S, Boelens JJ. Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution. Blood. 2016;128(23):2607–2615.
   PubMed Web of Science ®Google Scholar
• Han ZJ, Feng YH, Gu BH, et al. The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol. 2018;52(4):1081–1094.
   PubMed Web of Science ®Google Scholar
• Yang Y, He Y, Wang X, et al. Protein SUMOylation modification and its associations with disease. Open Biol. 2017;7(10):170167.
   PubMed Web of Science ®Google Scholar
• Wilson VG. Introduction to Sumoylation. Adv Exp Med Biol. 2017;963:1–12.
   PubMed Web of Science ®Google Scholar
• Kunz K, Piller T, Muller S. SUMO-specific proteases and isopeptidases of the SENP family at a glance. J Cell Sci. 2018;131(6):jcs211904.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D, Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sci. 2007;32(6):286–295.
   PubMed Web of Science ®Google Scholar
• Cheng J, Kang X, Zhang S, et al. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007;131(3):584–595.
   PubMed Web of Science ®Google Scholar
• Van Nguyen T, Angkasekwinai P, Dou H, et al. SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation. Mol Cell. 2012;45(2):210–221.
   PubMed Web of Science ®Google Scholar
• Saether T, Pattabiraman DR, Alm-Kristiansen AH, et al. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability. Oncogene. 2011;30(2):212–222.
   PubMed Web of Science ®Google Scholar
• Fleenor CJ, Arends T, Lei H, et al. Zinc finger protein 521 regulates early hematopoiesis through cell-extrinsic mechanisms in the bone marrow microenvironment. Mol Cell Biol. 2018;38(17):e00603–17.
   PubMed Web of Science ®Google Scholar
• Mega T, Lupia M, Amodio N, et al. Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors. Cell Cycle. 2011;10(13):2129–2139.
   PubMed Web of Science ®Google Scholar
• Matsubara E, Sakai I, Yamanouchi J, et al. The role of zinc finger protein 521/early hematopoietic zinc finger protein in erythroid cell differentiation. J Biol Chem. 2009;284(6):3480–3487.
   PubMed Web of Science ®Google Scholar
• Kiviranta R, Yamana K, Saito H, et al. Coordinated transcriptional regulation of bone homeostasis by Ebf1 and Zfp521 in both mesenchymal and hematopoietic lineages. J Exp Med. 2013;210(5):969–985.
   PubMed Web of Science ®Google Scholar
• Al Dallal S, Wolton K, Hentges KE. Zfp521 promotes B-cell viability and cyclin D1 gene expression in a B cell culture system. Leuk Res. 2016;46:10–17.
   PubMed Web of Science ®Google Scholar
• Wyatt D, Malik R, Vesecky AC, et al. Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J Biol Chem. 2011;286(5):3884–3893.
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhou F, Fu C, et al. SUMOsp: a web server for sumoylation site prediction. Nucleic Acids Res. 2006;34(WebServer issue):W254–7.
   PubMedGoogle Scholar
• Aggarwal R, Lu J, Pompili VJ, et al. Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application. Curr Mol Med. 2012;12(1):34–49.
   PubMed Web of Science ®Google Scholar
• Ganuza M, McKinney-Freeman S. Hematopoietic stem cells under pressure. Curr Opin Hematol. 2017;24(4):314–321.
   PubMed Web of Science ®Google Scholar
• Yu VW, Scadden DT. Hematopoietic stem cell and its bone marrow niche. Curr Top Dev Biol. 2016;118:21–44.
   PubMed Web of Science ®Google Scholar
• Stone HB, Coleman CN, Anscher MS, et al. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol. 2003;4(9):529–536.
   PubMed Web of Science ®Google Scholar
• Bialik P, Wozniak K. SUMO proteases as potential targets for cancer therapy. Postepy Hig Med Dosw (Online). 2017;71:997–1004.
   PubMedGoogle Scholar
• Anderson DB, Zanella CA, Henley JM, et al. Sumoylation: implications for neurodegenerative diseases. Adv Exp Med Biol. 2017;963:261–281.
   PubMed Web of Science ®Google Scholar
• He X, Riceberg J, Soucy T, et al. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor. Nat Chem Biol. 2017;13(11):1164–1171.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Saitoh H. Puromycin induces SUMO and ubiquitin redistribution upon proteasome inhibition. Biochem Biophys Res Commun. 2016;476(3):153–158.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li J, Khoury J, et al. Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. J Biol Chem. 2009;284(20):13686–13695.
   PubMed Web of Science ®Google Scholar
• Zhao B, Villhauer EB, Bhuripanyo K, et al. SUMO-mimicking peptides inhibiting protein SUMOylation. Chembiochem. 2014;15(18):2662–2666.
   PubMed Web of Science ®Google Scholar
• Li YJ, Du L, Wang J, et al. Allosteric inhibition of ubiquitin-like modifications by a class of inhibitor of SUMO-activating enzyme. Cell Chem Biol. 2019;26(2):278–288.
   PubMed Web of Science ®Google Scholar
• Lv Z, Yuan L, Atkison JH, et al. Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme. Nat Commun. 2018;9(1):5145.
   PubMedGoogle Scholar
• Wu J, Lei H, Zhang J, et al. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation. Oncotarget. 2016;7(37):58995–59005.
   PubMedGoogle Scholar
• Ambaye N, Chen CH, Khanna S, et al. Streptonigrin inhibits SENP1 and reduces the protein level of hypoxia-inducible factor 1alpha (HIF1alpha) in cells. Biochemistry. 2018;57(11):1807–1813.
   PubMed Web of Science ®Google Scholar